In this study we evaluated the role of insulin in hypertension and on salt sensitivity. The study was conducted in 47 consecutive patients attending the Center for the Detection and Treatment of Cardiovascular and Metabolic Risk factors. The relationships between fasting and post-glucose load insulin levels and the blood pressure (BP) responses to changes in salt intake, were investigated. No correlation was observed between fasting or 2-h post-load insulin levels and mean BP (MBP), systolic BP (SBP) or diastolic BP (DBP). The plasma concentrations of insulin were not significantly related to body mass index (BMI) (r 2 ‫؍‬ 0.05; P ‫؍‬ 0.135). Neither fasting nor 2-h post-load insulin predicted the BP response to changes in salt intake. A reduction in salt intake from 316 ؎ 13 to 26 PM 3 mmoles/day, produced similar BP lowering in subjects with fasting insulin Ͼ15 U/ml and in subjects with normal fasting insulin
Introduction
The incidence of hypertension is increased in obese subjects and in patients with non-insulin dependent diabetes mellitus (NIDDM). [1] [2] [3] [4] [5] Since compensatory hyperinsulinaemia is commonly observed in obesity and in early stages of NIDDM, it has been proposed that insulin may play a role in the aetiology of hypertension associated with these conditions. [6] [7] [8] [9] [10] [11] Acute administration of insulin has been shown to increase sympathetic nervous system activity and to induce sodium retention. [12] [13] [14] Interestingly, nonobese subjects with essential hypertension may also present a state of insulin resistance with the consequent compensatory hyperinsulinaemia. 15 These findings indicate that insulin resistance is commonly present in hypertension, obesity and NIDDM, and that the hyperinsulinaemia is worsened by the frequent coexistence of two or more conditions in one individual. 10 Recent studies have also shown a link between the salt-sensitive form of hypertension and insulin resistance. [16] [17] [18] [19] In addition, it has been shown that a high intake of salt may worsen insulin resistance, inducing hyperinsulinaemia in salt sensitive, but not in salt-resistant individuals. 18, 19 In order to further understand the role of insulin in hypertension and on salt sensitivity, we evaluated Correspondence: Dr Luigi X Cubeddu, Nova Southeastern University, HPD; 3200 S University Dr., Ft Lauderdale, FL 33328, USA levels (Ͻ15 U/ml). In addition, no relationship was observed between the magnitude of the BP responses to salt and the levels of insulin, either fasting (r 2 ‫؍‬ 0.007; P ‫؍‬ 0.86) or 2-h after a glucose load (r 2 ‫؍‬ 0.01; P ‫؍‬ 0.213). A very strong association was found between body weight or BMI and MBP (r 2 ‫؍‬ 0.443; P Ͻ 0.0001). In conclusion, our results are against the view of a cause-effect relationship between insulin and BP levels. In addition, the insulin status of a patient does not predict (nor determines) his (her) vascular reactivity to changes in salt intake. Finally, our findings further support the existence of a strong and direct association between body weight and hypertension, and speak against a major role of insulin in the pathogenesis of hypertension associated with obesity. Journal of Human Hypertension (2000) 14, Suppl 1, S32-S35.
whether the patient's response to changes in salt intake were dependent on fasting insulin levels or on the degree of insulinaemia achieved in response to an oral glucose load. In addition, we investigated the role of insulin as a predictor of the patient's blood pressure (BP). The study was conducted in 47 consecutive patients attending the Center for the Detection and Treatment of Cardiovascular and Metabolic Risk factors.
Materials and methods
A total of 47 consecutive patients attending our Center for the Detection and Treatment of Silent Cardiovascular and Metabolic Risk Factors were evaluated. The exclusion criteria were: age greater than 70 years; a history of angina pectoris, myocardial infarction, congestive heart failure, valvular heart disease, cerebral infarction or haemorrhage, transient ischaemic attacks, arteriosclerosis obliterans, pulmonary disease; any patient with active disease, evidences of renal or hepatic dysfunction, severe hypertension, diabetes mellitus, women on birth control pills, and serum creatinine concentration greater than 2 mg%. Any medication was discontinued at least 4 weeks before the sodium-sensitivity protocol was started.
An oral glucose tolerance test was performed in all patients. A 75 g oral glucose solution was administered after a 12-h overnight fast. Plasma levels of glucose and insulin were determined at 30, 60, 90, 120 and 180 min. Insulin was quantitated by radioimmunoassay (RIA) and glucose by the glucose oxidase method.
Determination of BP responses to changes in salt intake
Patients were given a liberal sodium intake diet, prescribing in addition a total of 12 tablets a day, each containing 1 g of sodium chloride. Subsequently, patients received a low-salt diet (20-40 mEq/day) for 7 days. On days 6 or 7 of both sodium diets, patients returned to the centre for the following procedures: systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR) and 24-h sodium excretion. BP was measured with a standard mercury sphygmomanometer. Korotkoff sounds 1 and 5 were used to record SBP and DBP, respectively. The BP measurements were done with the patient in the supine position after the patient had rested for at least 30 min. The average of at least three determinations was used. The mean BP was calculated as one-third of the pulse pressure added to the diastolic pressure.
Statistics.
Categorical variables were compared by means of the 2 test. Continuous variables were compared by the Student's t-test for independent samples and paired t-test for paired samples. Results are shown as mean values ± s.e.m.; differences were considered significant at a value of P Ͻ 0.05.
Results
The relationship between insulin, overweight and high BP were evaluated. A very strong association was found between body weight or BMI and MBP (r 2 = 0.443; P Ͻ 0.0001) (Figure 1) . A highly significant relationship was also observed when systolic or diastolic BPs were employed in the regression analysis (data not shown). Although obese individuals had higher fasting and 2-h post-load insulin concentrations than lean individuals (P Ͻ 0.01) ( Table 1) , no correlation was observed between fasting or 2-h post-load insulin levels and MBP, SBP or DBP (Figure 2 ). In addition, the plasma concentrations of insulin were not significantly related to BMI or body weight (r 2 = 0.05; P = 0.135). Subjects were stratified according to their fasting plasma insulin levels (Table 2) . BMI, body weight and MBP were higher in hyperinsulinaemic, although not statistically different from the values found in normoinsulinaemic individuals.
The effects of reductions in salt intake on BP were evaluated. Neither fasting nor 2-h post-load insulin predicted the BP response to changes in salt intake ( Figure 3) . A reduction in salt intake from 316 ± 13 to 26 ± 3 mmoles/day, produced similar BP lowering in subjects with fasting insulin Ͼ15 U/ml and in subjects with normal fasting insulin levels (Ͻ15 U/ml) (Figure 3 ). In addition, no relationships were observed between the magnitude of the BP responses to salt and the levels of insulin, either fasting (r 2 = 0.007; P = 0.86) or 2-h after a glucose load (r 2 = 0.01; P = 0.213).
Discussion
The present study further supports the existence of a strong relationship between body weight and BP levels; with higher BP in the patients with larger body weights and BMI. The mechanism(s) by which increased body weight leads to a higher BP is (are) unknown. 7, [20] [21] [22] Because of its salt retaining properties and stimulating actions on the sympathetic nervous system (SNS), insulin has been proposed to play a pathogenetic role in the hypertension of obese individuals. In addition, the incidence of hypertension is much higher in subjects with hyperinsulinaemia and/or insulin resistance; such as NIDDM and obesity. [1] [2] [3] [4] [5] Further, improvement of hyperinsulinaemia by body weight reduction is associated with BP lowering. 20, 21 However, despite the fact that our obese patients were hyperinsulinaemic, we failed to observe a relationship between fasting insulin concentrations and BP. Only the insulin levels obtained 2 h after the ingestion of 75 g of glucose (glucose tolerance test) showed a statistically significant correlation with the BP (P = 0.014), although the strength of the regression was weak (r 2 = 0.15). Several investigators have also failed to demonstrate an association between fasting insulin levels and BPs. For example, Pima Indians have a high incidence of hyperinsulinaemia despite their low prevalence of hypertension. 4 If insulin would be involved in the pathogenesis of hypertension associated with obesity, a strong relationship between insulin and BP should have been observed. Our results are against the view of a cause-effect relationship between hyperinsulinaemia and hypertension, and of insulin as a major determinant of the subject's BP. [23] [24] [25] Nevertheless these and other findings, do not rule out the possibility that insulin resistance/hyperinsulinaemia, may play a pathogenetic role in a specific patient's subset, such as the salt-sensitive form of hypertension.
Because of the salt-retaining salt and SNS stimulating actions of insulin, the role of insulin in the salt-sensitive form of hypertension has been investigated. Several studies have demonstrated that salt sensitive individuals are often insulin resistant. In fact, reductions in insulin-stimulated glucose disposal have been reported in salt-sensitive compared to salt-resistant individuals. [16] [17] [18] 26 However, in the present study, we failed to observe a relationship between fasting or 2 h post-load insulin levels and the magnitude of BP reduction induced by salt restriction. In fact, similar BP decreases were observed in normo-and hyperinsulinaemic individuals when the intake of salt was restricted from approximately 300 mmoles/day to nearly 30 mmoles/day. These observations indicate that the insulin status of a patient does not predict (nor determines) their vascular reactivity to changes in salt intake. In a previous study, in lean essential hypertensives, no differences in fasting insulin levels were observed between salt-sensitive and saltresistant patients. 18 However, in salt-sensitive hypertensives, fasting insulin levels increased and the severity of insulin resistance worsened during the high salt diet; whereas, no changes in these parameters were observed in salt-resistant hypertensives. 18 Since only the salt-sensitive experienced large BP increases when the intake of salt was augmented, it is possible that the worsening of the hypertension might have caused the deterioration in insulin resistance.
In conclusion, our findings speak against the role of insulin in determining a patient's BP and further support the existence of a strong and direct association between body weight and hypertension. In addition, our findings indicate, that neither the fasting levels of insulin nor the insulin response to a glucose load, predict or determine the subject's vascular reactivity to changes in salt intake.
